Preclinical models have demonstrated that interleukin-7 (IL-7) and IL-15 administration to irradiated mice resulted in greater tumor regression which was associated with an increase in CD8+ cytotoxic T cell counts without an increase in immunosuppressive regulatory T cell counts53–55. The gene discussed is IL7; the disease is neoplasm.